(AXTA) Axalta Coating Systems - Overview
Sector: Basic Materials | Industry: Specialty Chemicals | Exchange: NYSE (USA) | Market Cap: 6.234m USD | Total Return: -7.4% in 12m
Avg Turnover: 49.0M
EPS Trend: 93.6%
Qual. Beats: 0
Rev. Trend: 8.0%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Axalta Coating Systems Ltd. is a global manufacturer and distributor of high-performance liquid and powder coatings, serving the automotive, industrial, and commercial vehicle markets. The company operates through two primary segments: Performance Coatings, which focuses on vehicle refinishing and industrial applications, and Mobility Coatings, which provides chemical solutions for light and commercial vehicle original equipment manufacturers (OEMs).
As a key player in the specialty chemicals sector, Axalta utilizes a business model centered on high-barrier-to-entry technology and long-term supply contracts with global manufacturers. The coatings industry typically relies on recurring revenue streams from the automotive aftermarket, as refinish products are essential for vehicle repair regardless of new car sales cycles. Axalta maintains an extensive portfolio of proprietary brands, including Imron, Cromax, and Spies Hecker, to serve diverse end-markets ranging from architectural materials to aviation.
Investors can evaluate the underlying valuation metrics and historical performance of this stock by visiting ValueRay. Axaltas global infrastructure includes production facilities across North America, Europe, and the Asia Pacific, positioning it to capture demand in both established and emerging industrial corridors.
- Global automotive production volume recovery accelerates mobility segment revenue growth
- Raw material deflation improves gross margins across performance coatings portfolio
- Refinish market share gains drive consistent high-margin recurring cash flow
- Industrial end-market demand sensitivity impacts powder and liquid coating volumes
- Strategic price adjustments offset persistent logistics and labor cost inflation
| Net Income: 369.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.94 > 1.0 |
| NWC/Revenue: 28.95% < 20% (prev 28.43%; Δ 0.52% < -1%) |
| CFO/TA 0.09 > 3% & CFO 690.0m > Net Income 369.0m |
| Net Debt (2.57b) to EBITDA (1.02b): 2.52 < 3 |
| Current Ratio: 2.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (214.6m) vs 12m ago -2.19% < -2% |
| Gross Margin: 32.20% > 18% (prev 0.34%; Δ 3.19k% > 0.5%) |
| Asset Turnover: 68.26% > 50% (prev 70.76%; Δ -2.50% > 0%) |
| Interest Coverage Ratio: 3.94 > 6 (EBITDA TTM 1.02b / Interest Expense TTM 182.0m) |
| A: 0.20 (Total Current Assets 2.83b - Total Current Liabilities 1.35b) / Total Assets 7.56b |
| B: 0.28 (Retained Earnings 2.15b / Total Assets 7.56b) |
| C: 0.10 (EBIT TTM 717.0m / Avg Total Assets 7.48b) |
| D: 0.39 (Book Value of Equity 2.00b / Total Liabilities 5.09b) |
| Altman-Z'' = 3.27 = A |
| DSRI: 1.01 (Receivables 1.26b/1.28b, Revenue 5.11b/5.24b) |
| GMI: 1.05 (GM 32.20% / 33.91%) |
| AQI: 0.99 (AQ_t 0.45 / AQ_t-1 0.46) |
| SGI: 0.97 (Revenue 5.11b / 5.24b) |
| TATA: -0.04 (NI 369.0m - CFO 690.0m) / TA 7.56b) |
| Beneish M = -3.04 (Cap -4..+1) = AA |
As of May 24, 2026, the stock is trading at USD 29.22 with a total of 1,052,541 shares traded.
Over the past week, the price has changed by +8.99%,
over one month by -2.54%,
over three months by -14.19% and
over the past year by -7.44%.
Axalta Coating Systems has received a consensus analysts rating of 4.10. Therefore, it is recommended to buy AXTA.
- StrongBuy: 9
- Buy: 4
- Hold: 7
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 35.2 | 20.5% |
P/E Forward = 11.1607
P/S = 1.2203
P/B = 2.5751
P/EG = 2.0369
Revenue TTM = 5.11b USD
EBIT TTM = 717.0m USD
EBITDA TTM = 1.02b USD
Long Term Debt = 3.13b USD (from longTermDebt, last quarter)
Short Term Debt = 20.0m USD (from shortTermDebt, last quarter)
Debt = 3.18b USD (from shortLongTermDebtTotal, last quarter) + Leases 31.0m
Net Debt = 2.57b USD (calculated: Debt 3.18b - CCE 608.0m)
Enterprise Value = 8.80b USD (6.23b + Debt 3.18b - CCE 608.0m)
Interest Coverage Ratio = 3.94 (Ebit TTM 717.0m / Interest Expense TTM 182.0m)
EV/FCF = 18.04x (Enterprise Value 8.80b / FCF TTM 488.0m)
FCF Yield = 5.54% (FCF TTM 488.0m / Enterprise Value 8.80b)
FCF Margin = 9.55% (FCF TTM 488.0m / Revenue TTM 5.11b)
Net Margin = 7.22% (Net Income TTM 369.0m / Revenue TTM 5.11b)
Gross Margin = 32.20% ((Revenue TTM 5.11b - Cost of Revenue TTM 3.46b) / Revenue TTM)
Gross Margin QoQ = 31.10% (prev 31.46%)
Tobins Q-Ratio = 1.16 (Enterprise Value 8.80b / Total Assets 7.56b)
Interest Expense / Debt = 5.73% (Interest Expense 182.0m / Debt 3.18b)
Taxrate = 13.33% (14.0m / 105.0m)
NOPAT = 621.4m (EBIT 717.0m * (1 - 13.33%))
Current Ratio = 2.10 (Total Current Assets 2.83b / Total Current Liabilities 1.35b)
Debt / Equity = 1.31 (Debt 3.18b / totalStockholderEquity, last quarter 2.42b)
Debt / EBITDA = 2.52 (Net Debt 2.57b / EBITDA 1.02b)
Debt / FCF = 5.27 (Net Debt 2.57b / FCF TTM 488.0m)
Total Stockholder Equity = 2.33b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.93% (Net Income 369.0m / Total Assets 7.56b)
RoE = 15.85% (Net Income TTM 369.0m / Total Stockholder Equity 2.33b)
RoCE = 13.14% (EBIT 717.0m / Capital Employed (Equity 2.33b + L.T.Debt 3.13b))
RoIC = 10.03% (NOPAT 621.4m / Invested Capital 6.19b)
WACC = 7.84% (E(6.23b)/V(9.41b) * Re(9.31%) + D(3.18b)/V(9.41b) * Rd(5.73%) * (1-Tc(0.13)))
Discount Rate = 9.31% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -82.81 | Cagr: -1.28%
[DCF] Terminal Value 77.97% ; FCFF base≈456.4m ; Y1≈523.2m ; Y5≈770.0m
[DCF] Fair Price = 42.13 (EV 11.6b - Net Debt 2.57b = Equity 9.02b / Shares 214.0m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 93.60 | EPS CAGR: 21.29% | SUE: 0.77 | # QB: 0
Revenue Correlation: 7.98 | Revenue CAGR: 0.12% | SUE: 3.21 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.64 | Chg30d=-2.19% | Revisions=-33% | Analysts=15
EPS next Quarter (2026-09-30): EPS=0.71 | Chg30d=-5.52% | Revisions=-62% | Analysts=15
EPS current Year (2026-12-31): EPS=2.59 | Chg30d=-0.68% | Revisions=-41% | GrowthEPS=+3.9% | GrowthRev=+2.0%
EPS next Year (2027-12-31): EPS=2.81 | Chg30d=-0.32% | Revisions=-22% | GrowthEPS=+8.5% | GrowthRev=+3.6%
[Analyst] Revisions Ratio: -62%